Taysha Gene Therapies (TSHA) Prepaid Assets (2020 - 2026)

Taysha Gene Therapies has disclosed Prepaid Assets across 7 years of filings, most recently posting $5.2 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $5.2 million, up 2152.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (up 2152.16% YoY), and the FY2025 annual result was $108000.0, down 56.63% from the prior year.
• Prepaid Assets came in at $5.2 million for Q1 2026 at Taysha Gene Therapies, up from $108000.0 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $8.7 million in Q3 2022 to a low of $46000.0 in Q3 2025.
• The 5-year median for Prepaid Assets is $333000.0 (2023), against an average of $1.9 million.
• Across the five-year window, Prepaid Assets sank 98.65% in 2025 and surged 2152.16% in 2026, its largest moves.
• Taysha Gene Therapies' Prepaid Assets stood at $8.5 million in 2022, then slumped by 59.25% to $3.5 million in 2023, then tumbled by 92.84% to $249000.0 in 2024, then slumped by 56.63% to $108000.0 in 2025, then surged by 4737.96% to $5.2 million in 2026.
• The last three Prepaid Assets figures came in at $5.2 million (Q1 2026), $108000.0 (Q4 2025), and $46000.0 (Q3 2025), per Business Quant data.